Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spectrum and Clinical Activity of PD-1/PD-L1 Inhibitors: Regulatory Approval and Under Development
Leandro Jonata de Carvalho Oliveira, Aline Bobato Lara Gongora, Denis L. Jardim
Current Oncology Reports (2020) Vol. 22, Iss. 7
Closed Access | Times Cited: 16

Showing 16 citing articles:

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni, Helen K. Angell, Jérôme Galon
Nature reviews. Cancer (2020) Vol. 20, Iss. 11, pp. 662-680
Closed Access | Times Cited: 1205
Vaccines for immunoprevention of cancer
Tomohiro Enokida, Alvaro Moreira, Nina Bhardwaj
Journal of Clinical Investigation (2021) Vol. 131, Iss. 9
Open Access | Times Cited: 63
Reassessing Patterns of Response to Immunotherapy with PET: From Morphology to Metabolism
Larissa Bastos Costa, Marcelo A. Queiroz, Felipe de Galiza Barbosa, et al.
Radiographics (2020) Vol. 41, Iss. 1, pp. 120-143
Closed Access | Times Cited: 36
EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma
Anne Jenseit, Aylin Camgöz, Stefan M. Pfister, et al.
Acta Neuropathologica (2021) Vol. 143, Iss. 1, pp. 1-13
Open Access | Times Cited: 30
First‐line atezolizumab monotherapy in patients with advanced BRAFV600 wild‐type melanoma
Sérgio Jobim Azevedo, Andréia Cristina de Melo, Louise Roberts, et al.
Pigment Cell & Melanoma Research (2021) Vol. 34, Iss. 5, pp. 973-977
Closed Access | Times Cited: 27
Characterization of Hospital Admissions During Immune Checkpoint Inhibitor Therapy: Insights From the ICOG Study
Jonas Paul Wiegmann, Tabea Fröhlich, Nora Möhn, et al.
Cancer Medicine (2025) Vol. 14, Iss. 3
Open Access
Advancements in Melanoma Treatment: A Review of PD-1 Inhibitors, T-VEC, mRNA Vaccines, and Tumor-Infiltrating Lymphocyte Therapy in an Evolving Landscape of Immunotherapy
Apoorva Mehta, Mateen Motavaf, Ikenna David Nebo, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1200-1200
Open Access
Adrenergic Signaling in Immunotherapy of Cancer: Friend or Foe?
Agnete W.P. Jensen, Ana Micaela Carnaz Simões, Per thor Straten, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 394-394
Open Access | Times Cited: 26
Expression and Prognostic Value of the Immune Checkpoints Galectin-9 and PD-L1 in Glioblastomas
Arnon Møldrup Knudsen, Sisse Josephine Rudkjøbing, Mia Dahl Sørensen, et al.
Journal of Neuropathology & Experimental Neurology (2021) Vol. 80, Iss. 6, pp. 541-551
Open Access | Times Cited: 20
Cardiovascular toxicity following immune checkpoint inhibitors: A systematic review and meta-analysis
Camila Bragança Xavier, Carlos Diego Holanda Lopes, Guilherme Harada, et al.
Translational Oncology (2022) Vol. 19, pp. 101383-101383
Open Access | Times Cited: 9
Association among major adverse cardiovascular events with immune checkpoint inhibitors: A systematic review and meta‐analysis
Haixia Li, Yanfei Zheng, Bin Li, et al.
Journal of Internal Medicine (2024)
Open Access | Times Cited: 1
A systematic review of phase II trials exploring anti-PD-1/PD-L1 combinations in patients with solid tumors
Federica Martorana, Ilaria Colombo, Giorgio Treglia, et al.
Cancer Treatment Reviews (2021) Vol. 101, pp. 102300-102300
Closed Access | Times Cited: 10
Effect of AGEs-RAGE system on the efficacy of PD-1 inhibitors in the treatment of driver-gene mutation negative advanced non-squamous non-small cell lung cancer
Xiangying Li, Guan Wang, Xiuye Sun, et al.
Cellular and Molecular Biology (2023) Vol. 69, Iss. 14, pp. 155-160
Open Access | Times Cited: 1
Immunoimaging
Sikandar Shaikh
(2022), pp. 211-217
Closed Access | Times Cited: 1
Principles of Clinical Oncology and Systemic Treatments
Beatriz Mendes Awni, Marcello Moro Queiroz, Gustavo dos Santos Fernandes, et al.
Springer eBooks (2023), pp. 225-246
Closed Access
DNA Damage Response Inhibitor and Anti-PD-L1 Therapy for Prostate Cancer: Development of Predictive Biomarkers
Chuandong Geng, Timothy C. Thompson
Engineering (2022) Vol. 12, pp. 12-15
Open Access
Page 1

Scroll to top